• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

喉癌中预后生物标志物(Ki-67、Bcl-2、HIF-1α、细胞周期蛋白D1)与通过F-FDG PET/CT测量的代谢肿瘤体积的相关性。

The correlation of prognostic biomarkers (Ki-67, Bcl-2, HIF-1α, cyclin D1) with metabolic tumor volume measured by F-FDG PET/CT inlaryngeal cancer.

作者信息

Eryilmaz Aylin, Cengiz Arzu, Basal Yesim, Meteoglu Ibrahim, Omurlu Imran Kurt, Yurekli Yakup

机构信息

Department of Otorhinolaryngology, Faculty of Medicine, Adnan Menderes University, Aydin, Turkey.

Department of Nuclear Medicine, Faculty of Medicine, Adnan Menderes University, Aydin, Turkey.

出版信息

J Cancer Res Ther. 2018 Jul-Sep;14(5):994-998. doi: 10.4103/0973-1482.179162.

DOI:10.4103/0973-1482.179162
PMID:30197337
Abstract

OBJECTIVES

To investigate the correlation between tumor stage, Ki-67, Bcl-2, hypoxia inducible factor-1α (HIF-1α), cyclin D1 and metabolic tumor volume (MTV), total lesion glycolysis (TLG), maximum standardized uptake value (SUV) measured by F fluorodeoxyglucose positron emission tomography/computed tomography (FDG PET/CT) in patients diagnosed with laryngeal cancer.

PATIENTS AND METHODS

In this study, included 25 consecutive laryngeal cancer patients (2 women, 23 men) diagnosed and treated in the Otorhinolaryngology Department of our tertiary care center. All cases underwent F FDG PET/CT and SUV, mean standardized uptake value, MTV, and TLG values were calculated. Tumor staging was made and immunohistochemical staining was carried out for Ki-67, Bcl-2, HIF-1α and cyclin D1.

RESULTS

Eight (32%) patients had glottic laryngeal cancer, 6 (24%) had supraglottic laryngeal cancer and 11 (44%) had transglottic laryngeal cancer. Cyclin D1 was significantly correlated with MTV (r = 0.45, P = 0.03), TLG (r = 0.492, P = 0.01) and T-stage (r = 0.483, P = 0.02). Bcl-2 was significantly correlated with SUV (r = -0.41, P = 0.05) and tumor stage (r = -0.442, P = 0.03). MTV and TLG are significantly correlated with nodal stage (r = 0.422, P = 0.04, r = 0.419, P = 0.04), while TLG (r = 0.403, P = 0.05) and SUV (r = 0.440, P = 0.03) were correlated with tumor stage.

CONCLUSION

Our results indicated that biomarkers such as cyclin D1 and Bcl-2 were correlated with measures such as MTV, TLG, and SUV in F-FDG PET/CT. Integrative and combined evaluation of biomarkers and imaging data derived from F-FDG PET/CT are important for staging and appropriate management of patients with laryngeal cancer.

摘要

目的

探讨喉癌患者肿瘤分期、Ki-67、Bcl-2、缺氧诱导因子-1α(HIF-1α)、细胞周期蛋白D1与代谢肿瘤体积(MTV)、总病灶糖酵解(TLG)、通过氟脱氧葡萄糖正电子发射断层扫描/计算机断层扫描(FDG PET/CT)测量的最大标准化摄取值(SUV)之间的相关性。

患者与方法

本研究纳入了在我们三级医疗中心耳鼻喉科诊断并治疗的25例连续喉癌患者(2例女性,23例男性)。所有病例均接受了F FDG PET/CT检查,并计算了SUV、平均标准化摄取值、MTV和TLG值。进行了肿瘤分期,并对Ki-67、Bcl-2、HIF-1α和细胞周期蛋白D1进行了免疫组织化学染色。

结果

8例(32%)患者为声门型喉癌,6例(24%)为声门上型喉癌,11例(44%)为跨声门型喉癌。细胞周期蛋白D1与MTV(r = 0.45,P = 0.03)、TLG(r = 0.492,P = 0.01)和T分期(r = 0.483,P = 0.02)显著相关。Bcl-2与SUV(r = -0.41,P = 0.05)和肿瘤分期(r = -0.442,P = 0.03)显著相关。MTV和TLG与淋巴结分期显著相关(r = 0.422,P = 0.04,r = 0.419,P = 0.04),而TLG(r = 0.403,P = 0.05)和SUV(r = 0.440,P = 0.03)与肿瘤分期相关。

结论

我们的结果表明,细胞周期蛋白D1和Bcl-2等生物标志物与F-FDG PET/CT中的MTV、TLG和SUV等指标相关。对生物标志物和源自F-FDG PET/CT的影像数据进行综合评估,对于喉癌患者的分期和适当管理非常重要。

相似文献

1
The correlation of prognostic biomarkers (Ki-67, Bcl-2, HIF-1α, cyclin D1) with metabolic tumor volume measured by F-FDG PET/CT inlaryngeal cancer.喉癌中预后生物标志物(Ki-67、Bcl-2、HIF-1α、细胞周期蛋白D1)与通过F-FDG PET/CT测量的代谢肿瘤体积的相关性。
J Cancer Res Ther. 2018 Jul-Sep;14(5):994-998. doi: 10.4103/0973-1482.179162.
2
The correlation of F-FDG PET/CT metabolic parameters, clinicopathological factors, and prognosis in breast cancer.乳腺癌中 F-FDG PET/CT 代谢参数与临床病理因素及预后的相关性。
Clin Transl Oncol. 2021 Mar;23(3):620-627. doi: 10.1007/s12094-020-02457-w. Epub 2020 Jul 18.
3
Combination of circulating tumor cells and 18F-FDG PET/CT for precision diagnosis in patients with non-small cell lung cancer.循环肿瘤细胞与 18F-FDG PET/CT 联合应用于非小细胞肺癌患者的精准诊断。
Cancer Med. 2024 Sep;13(18):e70216. doi: 10.1002/cam4.70216.
4
Prognostic value of metabolic tumor burden from (18)F-FDG PET in surgical patients with non-small-cell lung cancer.(18)F-FDG PET 代谢肿瘤负荷对非小细胞肺癌手术患者的预后价值。
Acad Radiol. 2013 Jan;20(1):32-40. doi: 10.1016/j.acra.2012.07.002. Epub 2012 Sep 19.
5
Prognostic value of metabolic tumor burden on 18F-FDG PET in nonsurgical patients with non-small cell lung cancer.代谢肿瘤负荷 18F-FDG PET 在非手术治疗的非小细胞肺癌患者中的预后价值。
Eur J Nucl Med Mol Imaging. 2012 Jan;39(1):27-38. doi: 10.1007/s00259-011-1934-6. Epub 2011 Sep 23.
6
Prognostic value of F-FDG PET/CT parameters in patients who undergo salvage treatments for recurrent squamous cell carcinoma of the larynx and hypopharynx.18F-FDG PET/CT 参数在挽救治疗复发性喉和声门下鳞状细胞癌患者中的预后价值。
J Surg Oncol. 2018 Sep;118(4):644-650. doi: 10.1002/jso.25185. Epub 2018 Aug 21.
7
Prognostic significance of metabolic tumor volume and total lesion glycolysis in patients with advanced cervical carcinoma.代谢肿瘤体积和总病变糖酵解在晚期宫颈癌患者中的预后意义
Rev Esp Med Nucl Imagen Mol (Engl Ed). 2019 Jan-Feb;38(1):17-21. doi: 10.1016/j.remn.2018.08.001. Epub 2018 Oct 23.
8
Correlation study on 18F-FDG PET/CT metabolic characteristics of primary lesion with clinical stage in lung cancer.肺癌原发灶 18F-FDG PET/CT 代谢特征与临床分期的相关性研究。
Q J Nucl Med Mol Imaging. 2021 Jun;65(2):172-177. doi: 10.23736/S1824-4785.19.03146-7. Epub 2019 Mar 25.
9
Volume-based parameters on FDG PET may predict the proliferative potential of soft-tissue sarcomas.基于体素的FDG PET参数可能预测软组织肉瘤的增殖潜能。
Ann Nucl Med. 2019 Jan;33(1):22-31. doi: 10.1007/s12149-018-1298-0. Epub 2018 Sep 8.
10
Prognostic significance of standardized uptake value and metabolic tumour volume on ¹⁸F-FDG PET/CT in oropharyngeal squamous cell carcinoma.标准化摄取值和代谢肿瘤体积在¹⁸F-FDG PET/CT上对口咽鳞状细胞癌的预后意义
Eur J Nucl Med Mol Imaging. 2015 Aug;42(9):1353-61. doi: 10.1007/s00259-015-3051-4. Epub 2015 Jun 12.

引用本文的文献

1
MMP-9 and CCR7 as Possible Predictors of Lymph Node Metastasis in Laryngeal Squamous Cell Carcinoma.基质金属蛋白酶-9和趋化因子受体7作为喉鳞状细胞癌淋巴结转移的可能预测指标
Iran J Pathol. 2023 Spring;18(2):156-164. doi: 10.30699/ijp.2023.563014.2986. Epub 2023 Jun 20.
2
G870A Polymorphic Variants of Gene and Cyclin D1 Protein Expression as Prognostic Markers in Laryngeal Lesions.基因的G870A多态性变体及细胞周期蛋白D1蛋白表达作为喉病变的预后标志物
Diagnostics (Basel). 2022 Apr 23;12(5):1059. doi: 10.3390/diagnostics12051059.
3
Cyclin D1 Expression in Patients with Laryngeal Squamous Cell Carcinoma.
喉鳞状细胞癌患者中细胞周期蛋白D1的表达
Iran J Pathol. 2020 Summer;15(3):245-250. doi: 10.30699/ijp.2020.116579.2276. Epub 2020 May 1.